ATOS - Atossa Genetics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Cash Flow

All numbers in thousands
Period Ending12/31/201712/31/201612/31/2015
Net Income-8,122.581-6,368.885-15,760.323
Operating Activities, Cash Flows Provided By or Used In
Adjustments To Net Income1,739.5241,758.4923,842.239
Changes In Accounts Receivables---
Changes In Liabilities178.141-1,454.321732.447
Changes In Inventories--9.276
Changes In Other Operating Activities-518.028386.643-415.619
Total Cash Flow From Operating Activities-6,593.95-5,374.589-13,953.296
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures--9.213-130.735
Other Cash flows from Investing Activities---157.684
Total Cash Flows From Investing Activities--9.213-288.419
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid---
Sale Purchase of Stock10,783.4574,695.8699,456.892
Net Borrowings---
Other Cash Flows from Financing Activities---
Total Cash Flows From Financing Activities10,783.4574,695.8699,456.892
Effect Of Exchange Rate Changes---
Change In Cash and Cash Equivalents4,189.507-687.933-4,784.823